Shimizu, T, Kida, Y, Kuwano, K. Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors. Immunology
2004; 113: 121–129.
Marchetti, G, et al.
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4(+) cell count. AIDS
2011; 25: 1385–1394.
Freguja, R, et al.
Cross-talk between virus and host innate immunity in pediatric HIV-1 infection and disease progression. New Microbiologica
2012; 35: 249–257.
Imai, K, Ochiai, K, Okamoto, T. Microbial interaction between HIV-1 and anaerobic bacteria producing butyric acid: its potential implication in AIDS progression. Future Virology
2012; 7: 1005–1014.
Fierer, DS, et al.
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clinical Infectious Diseases
2013; 56: 1038–1043.
Baeten, JM, Overbaugh, J. Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission. Current HIV Research
2003; 1: 69–86.
Ferrer-Navarro, M, et al.
Proteome of the bacterium Mycoplasma penetrans
. Journal of Proteome Research
2006; 5: 688–694.
Waites, KB, Katz, B, Schelonka, RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clinical Microbiology Reviews
2005; 18: 757–789.
Rao, U, et al.
Pulmonary microbiology of HIV positive subjects with community-acquired pneumonia (CAP) with special emphasis on Mycoplasma pneumoniae
. International Journal of Infectious Diseases
2010; 14: E401–E401.
Razin, S, Yogev, D, Naot, Y. Molecular biology and pathogenicity of mycoplasmas. Microbiology and Molecular Biology Reviews
1998; 62: 1094–1156.
Jensen, JS. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. Journal of the European Academy of Dermatology and Venereology
2004; 18: 1–11.
Verteramo, R, et al.
An epidemiological survey of Mycoplasma hominis and Ureaplasma urealyticum in gynaecological outpatients, Rome, Italy. Epidemiology & Infection
2013; 141: 2650–2657.
Haggerty, CL, Ness, RB. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clinical Infectious Diseases
2007; 44: 953–960.
Taylor-Robinson, D. The role of mycoplasmas in pregnancy outcome. Best Practice & Research in Clinical Obstetrics & Gynaecology
2007; 21: 425–438.
Kataoka, S, et al.
Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. Journal of Clinical Microbiology
2006; 44: 51–55.
Taylor-Robinson, D, Jensen, JS.
Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clinical Microbiology Reviews
2011; 24: 498–514.
Bradshaw, CS, Chen, MY, Fairley, CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE
2008; 3: e3618.
Hjorth, SV, et al.
Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. Journal of Clinical Microbiology
2006; 44: 2078–2083.
Lo, SC, et al.
Newly discovered Mycoplasma isolated from patients infected with HIV. Lancet
1991; 338: 1415–1418.
Blanchard, A, Montagnier, L. AIDS-associated mycoplasmas. Annual Review of Microbiology
1994; 48: 687–712.
Balish, MF. Subcellular structures of mycoplasmas. Frontiers in Bioscience
2006; 11: 2017–2027.
Cohen, CR, et al.
Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sexually Transmitted Diseases
2007; 34: 274–279.
Iverson-Cabral, SL, et al.
Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences. Infection and Immunity
2006; 74: 3715–3726.
Seya, T, Matsumoto, M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. International Journal of Biochemistry & Cell Biology
2002; 34: 901–906.
Romero, F, et al.
In vivo immunomodulation by Mycoplasma fermentans membrane lipoprotein. Current Microbiology
2004; 48: 237–239.
Feng, SH, Lo, SC. Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans
. Infection and Immunity
1994; 62: 3916–3921.
Gatski, M, et al.
Mycoplasma genitalium infection among HIV-positive women: prevalence, risk factors and association with vaginal shedding. International Journal of STD & AIDS
2011; 22: 155–159.
Johnson, LF, Lewis, DA. the effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sexually Transmitted Diseases
2008; 35: 946–959.
Ghys, PD, et al.
The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS
1997; 11: F85–F93.
McClelland, RS, et al.
Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS
2001; 15: 105–110.
Sasaki, Y, et al.
Mycoplasmas stimulate replication of human immunodeficiency virus type 1 through selective activation of CD4+ T lymphocytes. AIDS Research and Human Retroviruses
1993; 9: 775–780.
McGowin, CL, et al.
Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infection and Immunity
2012; 80: 3842–3849.
Jian-Ru, W, et al.
Mycoplasmas in the urine of HIV-1 infected men. Epidemiology and Infection
2012; 140: 1141–1146.
Lusk, MJ, et al.
Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population. Sexually Transmitted Infections
2011; 87: 107–109.
Manhart, LE, et al.
High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. Journal of Infectious Diseases
2008; 197: 733–736.
Cordova, CMM, Blanchard, A, Cunha, RAF. Higher prevalence of urogenital mycoplasmas in human immunodeficiency virus-positive patients as compared to patients with other sexually transmitted diseases. Journal of Clinical Laboratory Analysis
2000; 14: 246–253.
da Costa, FAM, et al.
Prevalence of Mycoplasma genitalium among HIV-infected men in Sao Paulo city detected by realtime polymerase chain reaction. International Journal of STD & AIDS
2010; 21: 23–25.
Taylor-Robinson, D, Horner, PJ. The role of Mycoplasma genitalium in non-gonococcal urethritis. Sexually Transmitted Infections
2001; 77: 229–231.
Anagrius, C, Loré, B, Jensen, JS.
Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sexually Transmitted Infections
2005; 81: 458–462.